PAK6 and neoplasm: On the other hand, in the treatment of combination of oxaliplatin and AZD6738, the tumor volumes of the PAK6 overexpression xenografts were significantly reduced as compared with the volumes of the monotherapy of oxaliplatin (Fig. 7a, b).